HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

Abstract : In Western countries, tobacco smoking is highly prevalent among patients co-infected with HIV and hepatitis C virus (HCV). In the era of antiretrovirals and HCV cure, smoking-related health damages contribute greatly to morbidity and mortality in HIV-HCV co-infected patients. We used longitudinal data from the ANRS CO13 HEPAVIH cohort to identify the correlates of tobacco smoking quit attempts (TSQA) in HIV-HCV co-infected patients. TSQA were modelled using a multivariable discrete-time Cox proportional hazards model in 695 HIV-HCV co-infected tobacco smokers. HCV cure was associated with a 76% higher chance of TSQA (adjusted hazard ratio [95% confidence interval]: 1.76 [1.06-2.93], p = 0.029), and cannabis use with a 37% lower chance (0.63 [0.40-1.00], p = 0.049), independently of the mode of HIV transmission, other psychoactive substance use, and body mass index. Patients should be screened for tobacco and cannabis use at HCV treatment initiation and during follow-up. They should also be provided with comprehensive counselling and referral to addiction services. Non-smoking routes of cannabis administration should be promoted for cannabis users who wish to quit smoking tobacco.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03268540
Contributor : Oskar Admin Connect in order to contact the contributor
Submitted on : Friday, May 13, 2022 - 8:14:31 AM
Last modification on : Saturday, May 14, 2022 - 3:32:32 AM

File

BARRE_AIDS_B.pdf
Files produced by the author(s)

Identifiers

Citation

Tangui Barré, Patrick Mercie, Fabienne Marcellin, Laure Esterle, Claudine Duvivier, et al.. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study). AIDS and Behavior, Springer Verlag, 2021, 25, pp.4141-4153. ⟨10.1007/s10461-021-03277-x⟩. ⟨hal-03268540⟩

Share

Metrics

Record views

0

Files downloads

0